UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo Randomized, double-blind, placebo-controlled trial …
UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19 Read More »
